Ondansetron hydroch
Ended Awarded Last action
- Contract number
- SPE2DP25F051U
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$2,700 | |
| Original award | $2,700 |
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,699.90 for Ondansetron Hydrochloride on August 11, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was issued without a set-aside designation and falls under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at approximately $500 million and valid through November 2026. The place of performance is located in Park Ridge, Illinois, with funding provided through the Medical Supply Chain, a defense-focused federal agency component.
This delivery order represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain, specifically supporting Department of Defense healthcare facilities. Ondansetron Hydrochloride, commonly used as an anti-nausea medication in medical settings, exemplifies the type of pharmaceutical products the company routinely distributes to military health facilities. As a registered SAM.gov vendor since 2001, DMS Pharmaceutical Group has demonstrated sustained capability in delivering prescription medications, over-the-counter drugs, and specialty pharmaceuticals to federal agencies, leveraging its woman-owned small business status to compete effectively in federal procurement markets while supporting essential medical supply requirements across the Defense Department's healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DP25F051U?
SPE2DP25F051U was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 11, 2025.
How much is contract SPE2DP25F051U worth?
The government has obligated $0 on SPE2DP25F051U.
Is contract SPE2DP25F051U an order under another contract?
Yes. SPE2DP25F051U is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F051U competed?
The extent of competition for SPE2DP25F051U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award